Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer

por Witte, J H de, Sweep, C G J, Klijn, J G M, Grebenschikov, N, Peters, H A, Look, M P, Tienoven, ThH van, Heuvel, J J T M, Vries, J Bolt-De, Benraad, ThJ, Foekens, J A
Publicado 1999

The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy

por Manders, P, Beex, L V A M, Tjan-Heijnen, V C G, Geurts-Moespot, J, Van Tienoven, T H, Foekens, J A, Sweep, C G J
Publicado 2002

Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2

por Schuyer, M, Burg, M E L van der, Henzen-Logmans, S C, Fieret, J H, Klijn, J G M, Look, M P, Foekens, J A, Stoter, G, Berns, E M J J
Publicado 2001

Higher expression of human kallikrein 10 in breast cancer tissue predicts tamoxifen resistance

por Luo, L-Y, Diamandis, E P, Look, M P, Soosaipillai, A P, Foekens, J A
Publicado 2002

Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A...

por Schrohl, Anne-Sofie, Look, Maxime P, Meijer-van Gelder, Marion E, Foekens, John A, Brünner, Nils
Publicado 2009

CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer

por van Agthoven, T, Sieuwerts, A M, Veldscholte, J, Meijer-van Gelder, M E, Smid, M, Brinkman, A, den Dekker, A T, Leroy, I M, van IJcken, W F J, Sleijfer, S, Foekens, J A, Dorssers, L C J
Publicado 2009

Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer

por Liu, Ning Qing, Stingl, Christoph, Look, Maxime P., Smid, Marcel, Braakman, René B.H., De Marchi, Tommaso, Sieuwerts, Anieta M., Span, Paul N., Sweep, Fred C.G.J., Linderholm, Barbro K., Mangia, Anita, Paradiso, Angelo, Dirix, Luc Y., Van Laere, Steven J., Luider, Theo M., Martens, John W.M., Foekens, John A., Umar, Arzu
Publicado 2014

Int6 reduction activates stromal fibroblasts to enhance transforming activity in breast epithelial cells

por Suo, Jinfeng, Medina, Daniel, Herrera, Sabrina, Zheng, Ze-Yi, Jin, Lei, Chamness, Gary C, Contreras, Alejandro, Gutierrez, Carolina, Hilsenbeck, Susan, Umar, Arzu, Foekens, John A, Hanash, Samir, Schiff, Rachel, Zhang, Xiang H-F, Chang, Eric C
Publicado 2015

A Method to Correlate mRNA Expression Datasets Obtained from Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Tissue Samples: A Matter of Thresholds

por Mustafa, Dana A. M., Sieuwerts, Anieta M., Smid, Marcel, de Weerd, Vania, van der Weiden, Marcel, Meijer - van Gelder, Marion E., Martens, John W. M., Foekens, John A., Kros, Johan M.
Publicado 2015

An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients

por Reijm, Esther A., Sieuwerts, Anieta M., Smid, Marcel, Vries, Joan Bolt-de, Mostert, Bianca, Onstenk, Wendy, Peeters, Dieter, Dirix, Luc Y., Seynaeve, Caroline M., Jager, Agnes, de Jongh, Felix E., Hamberg, Paul, van Galen, Anne, Kraan, Jaco, Jansen, Maurice P. H. M., Gratama, Jan W., Foekens, John A., Martens, John W. M., Berns, Els M. J. J., Sleijfer, Stefan
Publicado 2016

Landscape of somatic mutations in 560 breast cancer whole genome sequences

por Nik-Zainal, Serena, Davies, Helen, Staaf, Johan, Ramakrishna, Manasa, Glodzik, Dominik, Zou, Xueqing, Martincorena, Inigo, Alexandrov, Ludmil B., Martin, Sancha, Wedge, David C., Van Loo, Peter, Ju, Young Seok, Smid, Marcel, Brinkman, Arie B, Morganella, Sandro, Aure, Miriam R., Lingjærde, Ole Christian, Langerød, Anita, Ringnér, Markus, Ahn, Sung-Min, Boyault, Sandrine, Brock, Jane E., Broeks, Annegien, Butler, Adam, Desmedt, Christine, Dirix, Luc, Dronov, Serge, Fatima, Aquila, Foekens, John A., Gerstung, Moritz, Hooijer, Gerrit KJ, Jang, Se Jin, Jones, David R., Kim, Hyung-Yong, King, Tari A., Krishnamurthy, Savitri, Lee, Hee Jin, Lee, Jeong-Yeon, Li, Yilong, McLaren, Stuart, Menzies, Andrew, Mustonen, Ville, O’Meara, Sarah, Pauporté, Iris, Pivot, Xavier, Purdie, Colin A., Raine, Keiran, Ramakrishnan, Kamna, Rodríguez-González, F. Germán, Romieu, Gilles, Sieuwerts, Anieta M., Simpson, Peter T, Shepherd, Rebecca, Stebbings, Lucy, Stefansson, Olafur A, Teague, Jon, Tommasi, Stefania, Treilleux, Isabelle, Van den Eynden, Gert G., Vermeulen, Peter, Vincent-Salomon, Anne, Yates, Lucy, Caldas, Carlos, van’t Veer, Laura, Tutt, Andrew, Knappskog, Stian, Tan, Benita Kiat Tee, Jonkers, Jos, Borg, Åke, Ueno, Naoto T, Sotiriou, Christos, Viari, Alain, Futreal, P. Andrew, Campbell, Peter J, Span, Paul N., Van Laere, Steven, Lakhani, Sunil R, Eyfjord, Jorunn E., Thompson, Alastair M., Birney, Ewan, Stunnenberg, Hendrik G, van de Vijver, Marc J, Martens, John W.M., Børresen-Dale, Anne-Lise, Richardson, Andrea L., Kong, Gu, Thomas, Gilles, Stratton, Michael R.
Publicado 2016

Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation

por Abubakar, Mustapha, Chang‐Claude, Jenny, Ali, H. Raza, Chatterjee, Nilanjan, Coulson, Penny, Daley, Frances, Blows, Fiona, Benitez, Javier, Milne, Roger L., Brenner, Hermann, Stegmaier, Christa, Mannermaa, Arto, Rudolph, Anja, Sinn, Peter, Couch, Fergus J., Devilee, Peter, Tollenaar, Rob A.E.M., Seynaeve, Caroline, Figueroa, Jonine, Lissowska, Jolanta, Hewitt, Stephen, Hooning, Maartje J., Hollestelle, Antoinette, Foekens, Renée, Koppert, Linetta B., Investigators, kConFab, Bolla, Manjeet K., Wang, Qin, Jones, Michael E., Schoemaker, Minouk J., Keeman, Renske, Easton, Douglas F., Swerdlow, Anthony J., Sherman, Mark E., Schmidt, Marjanka K., Pharoah, Paul D., Garcia‐Closas, Montserrat
Publicado 2018

The circular RNome of primary breast cancer

por Smid, Marcel, Wilting, Saskia M., Uhr, Katharina, Rodríguez-González, F. Germán, de Weerd, Vanja, Prager-Van der Smissen, Wendy J.C., van der Vlugt-Daane, Michelle, van Galen, Anne, Nik-Zainal, Serena, Butler, Adam, Martin, Sancha, Davies, Helen R., Staaf, Johan, van de Vijver, Marc J., Richardson, Andrea L., MacGrogan, Gaëten, Salgado, Roberto, van den Eynden, Gert G.G.M., Purdie, Colin A., Thompson, Alastair M., Caldas, Carlos, Span, Paul N., Sweep, Fred C.G.J., Simpson, Peter T., Lakhani, Sunil R., Van Laere, Steven, Desmedt, Christine, Paradiso, Angelo, Eyfjord, Jorunn, Broeks, Annegien, Vincent-Salomon, Anne, Futreal, Andrew P., Knappskog, Stian, King, Tari, Viari, Alain, Børresen-Dale, Anne-Lise, Stunnenberg, Hendrik G., Stratton, Mike, Foekens, John A., Sieuwerts, Anieta M., Martens, John W.M.
Publicado 2019

Interconnectivity between molecular subtypes and tumor stage in colorectal cancer

por Coebergh van den Braak, R. R. J., ten Hoorn, S., Sieuwerts, A. M., Tuynman, J. B., Smid, M., Wilting, S. M., Martens, J. W. M., Punt, C. J. A., Foekens, J. A., Medema, J. P., IJzermans, J. N. M., Vermeulen, L.
Publicado 2020

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer

por Bastiaansen, Anna E. M., Timmermans, A. Mieke, Smid, Marcel, van Deurzen, Carolien H. M., Hulsenboom, Esther S. P., Prager-van der Smissen, Wendy J. C., Foekens, Renée, Trapman-Jansen, Anita M. A. C., Sillevis Smitt, Peter A. E., Luider, Theo M., Martens, John W. M., vanDuijn, Martijn M.
Publicado 2020

HER2-low breast cancer shows a lower immune response compared to HER2-negative cases

por van den Ende, Nadine S., Smid, Marcel, Timmermans, Annemieke, van Brakel, Johannes B., Hansum, Tim, Foekens, Renée, Trapman, Anita M. A. C., Heemskerk-Gerritsen, Bernadette A. M., Jager, Agnes, Martens, John W. M., van Deurzen, Carolien H. M.
Publicado 2022

The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer.

por Nooter, K., Brutel de la Riviere, G., Look, M. P., van Wingerden, K. E., Henzen-Logmans, S. C., Scheper, R. J., Flens, M. J., Klijn, J. G., Stoter, G., Foekens, J. A.
Publicado 1997

miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs

por Riaz, Muhammad, van Jaarsveld, Marijn TM, Hollestelle, Antoinette, Prager-van der Smissen, Wendy JC, Heine, Anouk AJ, Boersma, Antonius WM, Liu, Jingjing, Helmijr, Jean, Ozturk, Bahar, Smid, Marcel, Wiemer, Erik A, Foekens, John A, Martens, John WM
Publicado 2013

High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as...

por Riaz, Muhammad, Sieuwerts, Anieta M, Look, Maxime P, Timmermans, Mieke A, Smid, Marcel, Foekens, John A, Martens, John WM
Publicado 2012

A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy

por McLaughlin, Ronan P., He, Jichao, van der Noord, Vera E., Redel, Jevin, Foekens, John A., Martens, John W. M., Smid, Marcel, Zhang, Yinghui, van de Water, Bob
Publicado 2019